Özgün Özçaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Özgün Özçaka has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Ayşe Nalbantsoy
Department of Bioengineering, Faculty of Engineering, Ege University, İzmir, Turkey
3 shared publicationsNurcan Buduneli
Department of Periodontology, School of Dentistry, Ege University, İzmir, Turkey
3 shared publicationsNurgün Bıçakcı
University of Ege, School of Dentistry, Department of Periodontology, İzmir, Turkey
3 shared publicationsAliye Akcali
Department of Periodontology, School of Dentistry, Ege University, İzmir, Turkey
2 shared publicationsN Buduneli
Ege University
2 shared publicationsPınar Gümüş
Department of Periodontology, School of Dentistry, Ege University, İzmir, Turkey
2 shared publications
Latest Publications
- Open Access
- 10 November 2025
- Published by Ondokuz Mayis Universitesi in Türk Diş Hekimliği Araştırma Dergisi
- Vol. 4 (3) , 181-189
Konjenital Nötropeni ve Periodontal Hastalıklar: Bağlantılar, Riskler ve Yönetim
Konjenital nötropeni, doğuştan gelen ve nötrofil granülosit sayısında belirgin azalmaya neden olan nadir bir hastalıktır. Periferik kanda üç ay boyunca mikrolitre (μL) başına 500’ün altında nötrofil sayısı olması kronik nötropeni olarak tanımlanır. Kronik nötropeninin altta yatan doğumsal nedenlere bağlı olarak gelişmesi ise konjenital nötropeni olarak adlandırılır. Konjenital nötropeni hastalarında, bağışıklık sisteminin enfeksiyonlara karşı korunma kapasitesi ciddi düzeyde azalır. Günümüzde 25’ten fazla gen mutasyonu, konjenital nötropeniye yol açabilmektedir. Periodontal hastalıklar, mikrobiyal dental plak ve konak yanıtı ile başlayan diş eti iltihabı ve destek dokuların yıkımı ile ilerleyen kronik, multifaktöriyel enfeksiyonlardır. Konjenital nötropeni hastalarında periodontal hastalıkların patofizyolojisi, nötrofillerin yetersizliği nedeniyle enfeksiyonlara karşı savunmanın zayıflaması ve enflamasyonun kontrol altına alınamaması ile ilişkilidir. Sürekli düşük seyreden nötrofil sayısı, oral mukozada ülserasyonlar, diş eti iltihabı ve hızlı ataşman kaybı gibi ciddi oral problemler yaratır. Bu durum, periodontitis gibi ilerleyici periodontal hastalıkların gelişmesine zemin hazırlar. Granülosit-koloni uyarıcı faktör (G-CSF) tedavisi, nötrofil sayısını artırarak enfeksiyon riskini azaltır. Ancak, geç kalınan veya yetersiz uygulanan tedavi periodontal hastalıkların şiddetini artırabilir. Bu derlemede, konjenital nötropeni ile periodontal hastalıklar arasındaki ilişki, ilgili patofizyolojik mekanizmalar ve periodontal tedavi yaklaşımları ele alınmaktadır. Konjenital nötropeni hastalarının tedavisinde hematolog ve diş hekimlerinin multidisipliner iş birliği, erken tanı ve etkin tedavi açısından kritik öneme sahiptir
- 10 November 2025
- Published by Ondokuz Mayis Universitesi in Türk Diş Hekimliği Araştırma Dergisi
- Vol. 4 (3) , 181-189
Open AccessKonjenital Nötropeni ve Periodontal Hastalıklar: Bağlantılar, Riskler ve Yönetim
Konjenital nötropeni, doğuştan gelen ve nötrofil granülosit sayısında belirgin azalmaya neden olan nadir bir hastalıktır. Periferik kanda üç ay boyunca mikrolitre (μL) başına 500’ün altında nötrofil sayısı olması kronik nötropeni olarak tanımlanır. Kronik nötropeninin altta yatan doğumsal nedenlere bağlı olarak gelişmesi ise konjenital nötropeni olarak adlandırılır. Konjenital nötropeni hastalarında, bağışıklık sisteminin enfeksiyonlara karşı korunma kapasitesi ciddi düzeyde azalır. Günümüzde 25’ten fazla gen mutasyonu, konjenital nötropeniye yol açabilmektedir. Periodontal hastalıklar, mikrobiyal dental plak ve konak yanıtı ile başlayan diş eti iltihabı ve destek dokuların yıkımı ile ilerleyen kronik, multifaktöriyel enfeksiyonlardır. Konjenital nötropeni hastalarında periodontal hastalıkların patofizyolojisi, nötrofillerin yetersizliği nedeniyle enfeksiyonlara karşı savunmanın zayıflaması ve enflamasyonun kontrol altına alınamaması ile ilişkilidir. Sürekli düşük seyreden nötrofil sayısı, oral mukozada ülserasyonlar, diş eti iltihabı ve hızlı ataşman kaybı gibi ciddi oral problemler yaratır. Bu durum, periodontitis gibi ilerleyici periodontal hastalıkların gelişmesine zemin hazırlar. Granülosit-koloni uyarıcı faktör (G-CSF) tedavisi, nötrofil sayısını artırarak enfeksiyon riskini azaltır. Ancak, geç kalınan veya yetersiz uygulanan tedavi periodontal hastalıkların şiddetini artırabilir. Bu derlemede, konjenital nötropeni ile periodontal hastalıklar arasındaki ilişki, ilgili patofizyolojik mekanizmalar ve periodontal tedavi yaklaşımları ele alınmaktadır. Konjenital nötropeni hastalarının tedavisinde hematolog ve diş hekimlerinin multidisipliner iş birliği, erken tanı ve etkin tedavi açısından kritik öneme sahiptir
- Open Access
- 18 August 2025
- Published by SDU Journal of Health Sciences in Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 16 (2) , 243-252
Oral Liken Planus Hastalarında Tükürük Kortizol Seviyesi, Kaygı Durumu ve Periodontal Enflamasyonun Değerlendirilmesi
Amaç: Çalışmanın amacı sağlıklı bireyler ve oral liken planus (OLP) hastalarında kaygı düzeylerinin ve tükürük kortizol seviyelerinin değerlendirilmesidir. Hastaların periodontal sağlıklarının belirlenerek karşılaştırılması da hedeflenmektedir. Yöntem: Katılımcılar E.Ü. Diş Hekimliği Fakültesine muayene amacıyla başvuran bireyler arasından belirlendi. OLP hasta grubu, ağızda OLP’ye bağlı yakınmaları olan ve OLP tanısı histopatolojik olan doğrulanmış hastalardan oluşturulurken, kontrol grubu rutin muayene amacıyla başvurmuş bireyler arasından seçildi. Demografik veriler kaydedildi ve hastalardan durumluk-sürekli anksiyete (STAI-II) ölçeğinin ikinci bölümünü doldurmaları istendi. Tükürük örnekleme sonrasında, plak ve kanama indeksleri ölçülerek periodontal durum değerlendirildi. Tükürük kortizol konsantrasyonları ticari bir kit kullanılarak belirlendi. Veriler t-testi, Mann-Whitney U testi ve ki-kare ve Pearson korelasyonu ile değerlendirildi (p0,05). Sondalamada kanama yüzdesi (p=0,368), plak yüzdesi (p=0,668) ve gingivitis varlığı (p=0,546) açısından anlamlı fark belirlenmedi. OLP grubun ortalama STAI-II değeri (47,54) kontrol grubuna oranla (42,60) anlamlı şekilde daha yüksekti (p=0,002). Ancak ortalama tükürük kortizol seviyelerinin sağlıklı grupta (3864,30 pg/ml) OLP grubuna kıyasla (3337,11 pg/ml) anlamlı şekilde daha yüksek olduğu belirlendi (p=0,005). Korelasyon analizleri, OLP grubunda yaş ve STAI-II skoru ile (p=0,020) sondalamada kanama yüzdesi (p=0,028) arasında pozitif bir ilişki varlığını gösterdi. Her iki grupta da STAI-II skoru ve tükürük kortizol seviyesi arasında anlamlı bir korelasyon gözlenmedi. Sonuç: OLP hastalarında psikolojik faktörlerin etkisi nöroendokrin etkenlerden daha baskın olabilir. Bu hastaların tedavisinde uygulanacak multidisipliner yaklaşıma psikolojik/psikiyatrik uzmanların da dahil edilmesi tedavi etkinliğinin ve hastanın yaşam kalitesinin artırılmasına önemli katkılar sağlayabilir.
- 18 August 2025
- Published by SDU Journal of Health Sciences in Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 16 (2) , 243-252
Open AccessOral Liken Planus Hastalarında Tükürük Kortizol Seviyesi, Kaygı Durumu ve Periodontal Enflamasyonun Değerlendirilmesi
Amaç: Çalışmanın amacı sağlıklı bireyler ve oral liken planus (OLP) hastalarında kaygı düzeylerinin ve tükürük kortizol seviyelerinin değerlendirilmesidir. Hastaların periodontal sağlıklarının belirlenerek karşılaştırılması da hedeflenmektedir. Yöntem: Katılımcılar E.Ü. Diş Hekimliği Fakültesine muayene amacıyla başvuran bireyler arasından belirlendi. OLP hasta grubu, ağızda OLP’ye bağlı yakınmaları olan ve OLP tanısı histopatolojik olan doğrulanmış hastalardan oluşturulurken, kontrol grubu rutin muayene amacıyla başvurmuş bireyler arasından seçildi. Demografik veriler kaydedildi ve hastalardan durumluk-sürekli anksiyete (STAI-II) ölçeğinin ikinci bölümünü doldurmaları istendi. Tükürük örnekleme sonrasında, plak ve kanama indeksleri ölçülerek periodontal durum değerlendirildi. Tükürük kortizol konsantrasyonları ticari bir kit kullanılarak belirlendi. Veriler t-testi, Mann-Whitney U testi ve ki-kare ve Pearson korelasyonu ile değerlendirildi (p0,05). Sondalamada kanama yüzdesi (p=0,368), plak yüzdesi (p=0,668) ve gingivitis varlığı (p=0,546) açısından anlamlı fark belirlenmedi. OLP grubun ortalama STAI-II değeri (47,54) kontrol grubuna oranla (42,60) anlamlı şekilde daha yüksekti (p=0,002). Ancak ortalama tükürük kortizol seviyelerinin sağlıklı grupta (3864,30 pg/ml) OLP grubuna kıyasla (3337,11 pg/ml) anlamlı şekilde daha yüksek olduğu belirlendi (p=0,005). Korelasyon analizleri, OLP grubunda yaş ve STAI-II skoru ile (p=0,020) sondalamada kanama yüzdesi (p=0,028) arasında pozitif bir ilişki varlığını gösterdi. Her iki grupta da STAI-II skoru ve tükürük kortizol seviyesi arasında anlamlı bir korelasyon gözlenmedi. Sonuç: OLP hastalarında psikolojik faktörlerin etkisi nöroendokrin etkenlerden daha baskın olabilir. Bu hastaların tedavisinde uygulanacak multidisipliner yaklaşıma psikolojik/psikiyatrik uzmanların da dahil edilmesi tedavi etkinliğinin ve hastanın yaşam kalitesinin artırılmasına önemli katkılar sağlayabilir.
- Open Access
- 30 July 2019
- Published by Editora Cubo in Brazilian Dental Science
- Vol. 22 (3) , 349-357
Altered levels of inhibitory cytokines in patients with thalassemia major and gingival inflammation
Objective: To evaluate local and systemic levels of interleukin-10 (IL-10), IL-33, and tumor necrosis factor alpha (TNF-?) in Thalassemia major (TM) in the presence of gingival inflammation. Material and Methods: 58 patients (TM, n=29 and systemically healthy controls, n=29) were included to the study. IL-10, IL-33, and TNF-? levels were evaluated in gingival crevicular fluid (GCF), saliva and serum. Clinical periodontal measurements were recorded. Results: GCF IL-33 total amounts in TM and gingivitis group were elevated compared to systemically and periodontally healthy group (p=0.01). GCF IL-10, IL-33 and TNF-? concentrations were higher in TM and periodontally healthy group than the systemically healthy and gingivitis group (p=0.02, p=0.008, p=0.003). Serum IL-10 levels were elevated in TM and gingivitis compared to the systemically healthy and gingivitis (p=0.0009) and systemically and periodontally healthy (p=0.0007) groups. Serum IL-10 and TNF-? levels in TM and periodontally healthy group were higher than systemically and periodontally healthy group (p=0.01 and p=0.02). Conclusion: TM may potentially alter circulating levels of IL-33 and IL-10 and therefore, may affect the degree of periodontal inflammation locally or vice versa. Yet, the underlying mechanism linking the hematologic condition is not clear and deserves further investigation. KeywordsGingivitis; Thalassemia major; Interleukin-10; Interleukin-33; Tumor Necrosis Factor-alpha.
- 30 July 2019
- Published by Editora Cubo in Brazilian Dental Science
- Vol. 22 (3) , 349-357
Open AccessAltered levels of inhibitory cytokines in patients with thalassemia major and gingival inflammation
Objective: To evaluate local and systemic levels of interleukin-10 (IL-10), IL-33, and tumor necrosis factor alpha (TNF-?) in Thalassemia major (TM) in the presence of gingival inflammation. Material and Methods: 58 patients (TM, n=29 and systemically healthy controls, n=29) were included to the study. IL-10, IL-33, and TNF-? levels were evaluated in gingival crevicular fluid (GCF), saliva and serum. Clinical periodontal measurements were recorded. Results: GCF IL-33 total amounts in TM and gingivitis group were elevated compared to systemically and periodontally healthy group (p=0.01). GCF IL-10, IL-33 and TNF-? concentrations were higher in TM and periodontally healthy group than the systemically healthy and gingivitis group (p=0.02, p=0.008, p=0.003). Serum IL-10 levels were elevated in TM and gingivitis compared to the systemically healthy and gingivitis (p=0.0009) and systemically and periodontally healthy (p=0.0007) groups. Serum IL-10 and TNF-? levels in TM and periodontally healthy group were higher than systemically and periodontally healthy group (p=0.01 and p=0.02). Conclusion: TM may potentially alter circulating levels of IL-33 and IL-10 and therefore, may affect the degree of periodontal inflammation locally or vice versa. Yet, the underlying mechanism linking the hematologic condition is not clear and deserves further investigation. KeywordsGingivitis; Thalassemia major; Interleukin-10; Interleukin-33; Tumor Necrosis Factor-alpha.
- 17 August 2018
- Published by Wiley in Journal of Periodontology
- Vol. 89 (8) , 959-965
Clinical periodontal status and inflammatory cytokines in primary Sjögren syndrome and rheumatoid arthritis
Background: The aim of the present study is to compare the clinical periodontal findings as well as gingival crevicular fluid (GCF) and plasma levels of tumor necrosis factor‐alpha (TNF‐α), interleukin‐1beta (IL‐1β), interferon gamma (IFN‐γ) and caspase‐1 in primary Sjögren syndrome (pSS) and rheumatoid arthritis (RA) subjects.Methods: In the present case control study plasma and GCF samples were collected, full‐mouth recordings comprising plaque index (PI), bleeding on probing (BOP) and probing depth (PD) were performed in 44 subjects with pSS, 39 subjects with RA and 30 systemically healthy subjects. Plasma and GCF TNF‐α, IL‐1β, IFN‐gamma and caspase‐1 levels were determined by enzyme‐linked immunosorbent assay.Results: There were no differences in GCF and plasma levels of IFN‐γ and TNF‐α in all the study groups (p > 0.05). GCF levels of IL‐1β were higher in pSS group than healthy group (p = 0.035). Caspase‐1 GCF levels were significantly higher in pSS group than RA group (p = 0.032). Highest plasma IL‐1β levels were detected in pSS compared to RA and healthy groups (p < 0.001). Healthy group has higher caspase‐1 plasma levels than pSS and RA groups (p < 0.001).Conclusions: The results of the present study reveal that the periodontal status of patients with pSS does not differ from systemically healthy subjects. Further studies involving longitudinal assessments on larger populations with standardized patient inclusion criteria are needed to confirm the findings.
- 17 August 2018
- Published by Wiley in Journal of Periodontology
- Vol. 89 (8) , 959-965
Clinical periodontal status and inflammatory cytokines in primary Sjögren syndrome and rheumatoid arthritis
Background: The aim of the present study is to compare the clinical periodontal findings as well as gingival crevicular fluid (GCF) and plasma levels of tumor necrosis factor‐alpha (TNF‐α), interleukin‐1beta (IL‐1β), interferon gamma (IFN‐γ) and caspase‐1 in primary Sjögren syndrome (pSS) and rheumatoid arthritis (RA) subjects.Methods: In the present case control study plasma and GCF samples were collected, full‐mouth recordings comprising plaque index (PI), bleeding on probing (BOP) and probing depth (PD) were performed in 44 subjects with pSS, 39 subjects with RA and 30 systemically healthy subjects. Plasma and GCF TNF‐α, IL‐1β, IFN‐gamma and caspase‐1 levels were determined by enzyme‐linked immunosorbent assay.Results: There were no differences in GCF and plasma levels of IFN‐γ and TNF‐α in all the study groups (p > 0.05). GCF levels of IL‐1β were higher in pSS group than healthy group (p = 0.035). Caspase‐1 GCF levels were significantly higher in pSS group than RA group (p = 0.032). Highest plasma IL‐1β levels were detected in pSS compared to RA and healthy groups (p < 0.001). Healthy group has higher caspase‐1 plasma levels than pSS and RA groups (p < 0.001).Conclusions: The results of the present study reveal that the periodontal status of patients with pSS does not differ from systemically healthy subjects. Further studies involving longitudinal assessments on larger populations with standardized patient inclusion criteria are needed to confirm the findings.
- 1 August 2017
- Published by Elsevier in Oral Oncology
- Vol. 71, 96-98
Inflammation in the assessment of salivary cytokines in oral squamous cell carcinoma diagnosis
- 1 August 2017
- Published by Elsevier in Oral Oncology
- Vol. 71, 96-98
Inflammation in the assessment of salivary cytokines in oral squamous cell carcinoma diagnosis
- 1 December 2016
- Published by Elsevier in Archives of Oral Biology
- Vol. 72, 87-91
Clinical periodontal status and inflammatory cytokines in gestational diabetes mellitus
- 1 December 2016
- Published by Elsevier in Archives of Oral Biology
- Vol. 72, 87-91
Clinical periodontal status and inflammatory cytokines in gestational diabetes mellitus
- 2 January 2016
- Published by Elsevier in Archives of Oral Biology
- Vol. 64, 80-84
Association of thalassemia major and gingival inflammation: A pilot study
- 2 January 2016
- Published by Elsevier in Archives of Oral Biology
- Vol. 64, 80-84
Association of thalassemia major and gingival inflammation: A pilot study
- 1 September 2014
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 59 (2) , 474-479
Periodontal disease and systemic diseases in an older population
- 1 September 2014
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 59 (2) , 474-479
Periodontal disease and systemic diseases in an older population
- 1 December 2012
- Published by Wiley in Journal of Periodontology
- Vol. 83 (12) , 1529-1537
Is There an Interaction Between Polycystic Ovary Syndrome and Gingival Inflammation?
Background: The aim of this study is to evaluate the gingival crevicular fluid (GCF), saliva, and serum concentrations of tumor necrosis factor‐α (TNF‐α), TNF‐α receptor‐1 (TNF‐αR1), TNF‐αR2, and interleukin‐6 (IL‐6) in non‐obese females with polycystic ovary syndrome (PCOS) and either clinically healthy periodontium or gingivitis.Methods: Thirty‐one females with PCOS and healthy periodontium, 30 females with PCOS and gingivitis, and 12 systemically and periodontally healthy females were included in the study. GCF, saliva, and serum samples were collected, and clinical periodontal measurements, body mass index, and Ferriman‐Gallwey score (FGS) were recorded. Sex hormones, cortisol, and insulin levels were measured. TNF‐α, TNF‐αR1, TNF‐αR2, and IL‐6 were determined by enzyme‐linked immunosorbent assay. Kruskal‐Wallis followed by Bonferroni‐corrected post hoc Mann‐Whitney U tests were used to analyze the data.Results: The PCOS + gingivitis group revealed significantly higher GCF, saliva, and serum IL‐6 concentrations than the PCOS + healthy group (P P = 0.024 and P = 0.013, respectively). The FGS index was significantly higher in the PCOS + gingivitis group than the PCOS + healthy group (P = 0.030). The PCOS + gingivitis group revealed significantly higher insulin concentration than the PCOS + healthy and control groups (P = 0.014 and P Conclusions: PCOS and gingival inflammation appear to act synergistically on the proinflammatory cytokines IL‐6 and TNF‐α. Thus, PCOS may have an impact on gingival inflammation or vice versa. Additional studies are warranted to clarify the possible relationship between PCOS and periodontal disease.
- 1 December 2012
- Published by Wiley in Journal of Periodontology
- Vol. 83 (12) , 1529-1537
Is There an Interaction Between Polycystic Ovary Syndrome and Gingival Inflammation?
Background: The aim of this study is to evaluate the gingival crevicular fluid (GCF), saliva, and serum concentrations of tumor necrosis factor‐α (TNF‐α), TNF‐α receptor‐1 (TNF‐αR1), TNF‐αR2, and interleukin‐6 (IL‐6) in non‐obese females with polycystic ovary syndrome (PCOS) and either clinically healthy periodontium or gingivitis.Methods: Thirty‐one females with PCOS and healthy periodontium, 30 females with PCOS and gingivitis, and 12 systemically and periodontally healthy females were included in the study. GCF, saliva, and serum samples were collected, and clinical periodontal measurements, body mass index, and Ferriman‐Gallwey score (FGS) were recorded. Sex hormones, cortisol, and insulin levels were measured. TNF‐α, TNF‐αR1, TNF‐αR2, and IL‐6 were determined by enzyme‐linked immunosorbent assay. Kruskal‐Wallis followed by Bonferroni‐corrected post hoc Mann‐Whitney U tests were used to analyze the data.Results: The PCOS + gingivitis group revealed significantly higher GCF, saliva, and serum IL‐6 concentrations than the PCOS + healthy group (P P = 0.024 and P = 0.013, respectively). The FGS index was significantly higher in the PCOS + gingivitis group than the PCOS + healthy group (P = 0.030). The PCOS + gingivitis group revealed significantly higher insulin concentration than the PCOS + healthy and control groups (P = 0.014 and P Conclusions: PCOS and gingival inflammation appear to act synergistically on the proinflammatory cytokines IL‐6 and TNF‐α. Thus, PCOS may have an impact on gingival inflammation or vice versa. Additional studies are warranted to clarify the possible relationship between PCOS and periodontal disease.
- 29 February 2012
- Published by Wiley in Journal of Periodontal Research
- Vol. 47 (5) , 584-592
Chlorhexidine decreases the risk of ventilator‐associated pneumonia in intensive care unit patients: a randomized clinical trial
Özçaka Ö, Başoğlu ÖK, Buduneli N, Taşbakan MS, Bacakoğlu F, Kinane DF. Chlorhexidine decreases the risk of ventilator‐associated pneumonia in intensive care unit patients: a randomized clinical trial. J Periodont Res 2012; 47: 584–592. © 2012 John Wiley & Sons A/SBackground and Objective: The aim was to evaluate whether oral swabbing with 0.2% chlorhexidine gluconate (CHX) decreases the risk of ventilator‐associated pneumonia (VAP) in intensive care unit (ICU) patients.Material and Methods: Sixty‐one dentate patients scheduled for invasive mechanical ventilation for at least 48 h were included in this randomized, double‐blind, controlled study. As these patients were variably incapacitated, oral care was provided by swabbing the oral mucosa four times/d with CHX in the CHX group (29 patients) and with saline in the control group (32 patients). Clinical periodontal measurements were recorded, and lower‐respiratory‐tract specimens were obtained for microbiological analysis on admission and when VAP was suspected. Pathogens were identified by quantifying colonies using standard culture techniques.Results: Ventilator‐associated pneumonia developed in 34/61 patients (55.7%) within 6.8 d. The VAP development rate was significantly higher in the control group than in the CHX group (68.8% vs. 41.4%, respectively; p = 0.03) with an odds ratio of 3.12 (95% confidence interval = 1.09–8.91). Acinetobacter baumannii was the most common pathogen (64.7%) of all species identified. There were no significant differences between the two groups in clinical periodontal measurements, VAP development time, pathogens detected or mortality rate.Conclusion: The finding of the present study, that oral care with CHX swabbing reduces the risk of VAP development in mechanically ventilated patients, strongly supports its use in ICUs and indeed the importance of adequate oral hygiene in preventing medical complications.
- 29 February 2012
- Published by Wiley in Journal of Periodontal Research
- Vol. 47 (5) , 584-592
Chlorhexidine decreases the risk of ventilator‐associated pneumonia in intensive care unit patients: a randomized clinical trial
Özçaka Ö, Başoğlu ÖK, Buduneli N, Taşbakan MS, Bacakoğlu F, Kinane DF. Chlorhexidine decreases the risk of ventilator‐associated pneumonia in intensive care unit patients: a randomized clinical trial. J Periodont Res 2012; 47: 584–592. © 2012 John Wiley & Sons A/SBackground and Objective: The aim was to evaluate whether oral swabbing with 0.2% chlorhexidine gluconate (CHX) decreases the risk of ventilator‐associated pneumonia (VAP) in intensive care unit (ICU) patients.Material and Methods: Sixty‐one dentate patients scheduled for invasive mechanical ventilation for at least 48 h were included in this randomized, double‐blind, controlled study. As these patients were variably incapacitated, oral care was provided by swabbing the oral mucosa four times/d with CHX in the CHX group (29 patients) and with saline in the control group (32 patients). Clinical periodontal measurements were recorded, and lower‐respiratory‐tract specimens were obtained for microbiological analysis on admission and when VAP was suspected. Pathogens were identified by quantifying colonies using standard culture techniques.Results: Ventilator‐associated pneumonia developed in 34/61 patients (55.7%) within 6.8 d. The VAP development rate was significantly higher in the control group than in the CHX group (68.8% vs. 41.4%, respectively; p = 0.03) with an odds ratio of 3.12 (95% confidence interval = 1.09–8.91). Acinetobacter baumannii was the most common pathogen (64.7%) of all species identified. There were no significant differences between the two groups in clinical periodontal measurements, VAP development time, pathogens detected or mortality rate.Conclusion: The finding of the present study, that oral care with CHX swabbing reduces the risk of VAP development in mechanically ventilated patients, strongly supports its use in ICUs and indeed the importance of adequate oral hygiene in preventing medical complications.